Motor axonal sprouting and neuromuscular junction loss in an animal model of charcot-marie-tooth disease

Journal of Neuropathology and Experimental Neurology

Volumn 69, Issue 3, 2010, Pages 281-293

  Ang, Eng Tat ^a   Schäfer, Ralf ^b   Baltensperger, Richard ^c   Wernig, Anton ^b   Celio, Marco ^a   Oliver, Sara Sancho ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITY OF BONN   (Germany)

^c Ecole d'Ingenieurs et d'Architectes de Fribourg   (Switzerland)

Author keywords

Animal model; Axon sprouting; Charcot Marie Tooth disease; Muscle fiber morphometry; Neuromuscular junction; PMP22; Synaptic transmission

Indexed keywords

ACETYLCHOLINE; PERIPHERAL MYELIN PROTEIN 22; YELLOW FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOLOGY; LONGITUDINAL STUDY; MALE; MORPHOMETRICS; MOTOR NERVE; MOTOR PERFORMANCE; MOUSE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE INNERVATION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MASS; NERVE SPROUTING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY; ROTAROD TEST; SOLEUS MUSCLE; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GROWTH CONES; HINDLIMB; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE CONTRACTION; MUSCLE WEAKNESS; MUSCULAR ATROPHY; NERVE REGENERATION; NEUROMUSCULAR JUNCTION; NEURONAL PLASTICITY; PERIPHERAL NERVES; SYNAPTIC TRANSMISSION;

EID: 77649266851     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181d1e60f     Document Type: Article

References (57)

1. Grandis M, Shy ME. Current therapy for Charcot-Marie-Tooth disease. Curr Treat Options Neurol 2005;7:23-31
2. Shy ME, Rose MR. Charcot-Marie-Tooth disease impairs quality of life: Why? And how do we improve it? Neurology 2005;65:790-791
3. Nelis E, Van Broeckhoven C, De Jonghe P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A European collaborative study. Eur J Hum Genet 1996;4:25-33 (Pubitemid 26094167)
4. Wise CA, Garcia CA, Davis SN, et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993;53:853-863
5. Thomas PK, Marques W Jr, Davis MB, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997;120(Pt 3): 465-78
6. Vinci P, Perelli SL. Footdrop, foot rotation, and plantarflexor failure in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2002;83:513-516
7. Garcia A, Combarros O, Calleja J, et al. Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: A longitudinal clinical and electrophysiologic study. Neurology 1998;50: 1061-67
8. Killian JM, Tiwari PS, Jacobson S, et al. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 1996;19:74-78
9. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101 (Pubitemid 23188823)
10. Valentijn LJ, Baas F, Wolterman RA, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;2:288-291
11. Gabreels-Festen AA, Gabreels FJ, Jennekens FG, et al. The status of HMSN type III. Neuromuscul Disord 1994;4:63-69
12. Gabreels-Festen AA, Bolhuis PA, Hoogendijk JE, et al. Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995;90: 645-49
13. Thomas PK, King RH, Small JR, et al. The pathology of Charcot-Marie-Tooth disease and related disorders. Neuropathol Appl Neurobiol 1996; 22:269-284
14. Hattori N, Yamamoto M, Yoshihara T, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): A clinicopathological study of 205 Japanese patients. Brain 2003;126:134-151
15. Ericson U, Ansved T, Borg K. Charcot-Marie-Tooth diseaseVmuscle biopsy findings in relation to neurophysiology. Neuromuscul Disord 1998; 8:175-181
16. Huxley C, Passage E, Manson A, et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 1996;5:563-569
17. Magyar JP, Martini R, Ruelicke T, et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 1996;16:5351-5360
18. Robertson AM, Perea J, McGuigan A, et al. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J Anat 2002;200:377-390
19. Sereda M, Griffiths I, Puhlhofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996;16:1049-1060
20. Huxley C, Passage E, Robertson AM, et al. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 1998;7:449-458
21. Adlkofer K, Martini R, Aguzzi A, et al. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 1995;11:274-280
22. Sancho S, Magyar JP, Aguzzi A, et al. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 1999;122(Pt 8):1563-1577
23. Frei R, Motzing S, Kinkelin I, et al. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci 1999;19:6058-6067
24. Yin X, Kidd GJ, Pioro EP, et al. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. J Neurosci 2004; 24:3890-3898
25. Wernig A, Carmody JJ, Anzil AP, et al. Persistence of nerve sprouting with features of synapse remodelling in soleus muscles of adult mice. Neuroscience 1984;11:241-253
26. Slawinska U, Tyc F, Kasicki S, et al. Time course of changes in EMG activity of fast muscles after partial denervation. Exp Brain Res 1998; 120:193-201
27. Wernig A, Herrera AA. Sprouting and remodelling at the nerve-muscle junction. Prog Neurobiol 1986;27:251-291
28. Gale AN, Gomez S, Duchen LW. Changes produced by a hypomyeli-nating neuropathy in muscle and its innervation. Morphological and physiological studies in the Trembler mouse. Brain 1982;105:373-393
29. Maier M, Berger P, Suter U. Understanding Schwann cell-neurone interactions: The key to Charcot-Marie-Tooth disease? J Anat 2002;200: 357-66
30. Feng G, Mellor RH, Bernstein M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000;28:41-51
31. Mouton PR, Gokhale AM, Ward NL, et al. Stereological length estimation using spherical probes. J Microsc 2002;206:54-64
32. Schmitz C, Hof PR. Design-based stereology in neuroscience. Neuro-science 2005;130:813-831
33. Irintchev A, Draguhn A, Wernig A. Reinnervation and recovery of mouse soleus muscle after long-term denervation. Neuroscience 1990;39:231-243
34. Wernig A, Zweyer M, Irintchev A. Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J Physiol 2000;522(Pt 2):333-345
35. Norreel JC, Jamon M, Riviere G, et al. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur J Neurosci 2001;13: 1625-34
36. Pun S, Sigrist M, Santos AF, et al. An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron 2002;34:357-370
37. Santos AF, Caroni P. Assembly, plasticity and selective vulnerability to disease of mouse neuromuscular junctions. J Neurocytol 2003;32:849-862
38. Pun S, Santos AF, Saxena S, et al. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 2006;9:408-419
39. Schaefer AM, Sanes JR, Lichtman JW. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 2005;490:209-219
40. Witzemann V, Schwarz H, Koenen M, et al. Acetylcholine receptor epsilon-subunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proc Natl Acad Sci USA 1996;93:13286-13291
41. Lichtman JW, Colman H. Synapse elimination and indelible memory. Neuron 2000;25:269-278
42. Sadeh M, Gilad R, Dabby R, et al. Apparent weakness of ulnar-innervated muscles in radial palsy. Neurology 2004;62:1424-1425
43. Rich MM, Lichtman JW. In vivo visualization of pre-and postsynaptic changes during synapse elimination in reinnervated mouse muscle. J Neurosci 1989;9:1781-1805
44. Brown MC, Hopkins WG, Keynes RJ, et al. A comparison of early morphological changes at denervated and paralyzed endplates in fast and slow muscles of the mouse. Brain Res 1982;248:382-386
45. Frey D, Schneider C, Xu L, et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 2000;20:2534-2542
46. Schafer R, Wernig A. Polyclonal antibodies against NCAM reduce paralysis-induced axonal sprouting. J Neurocytol 1998;27:615-624
47. Brown MC, Holland RL, Hopkins WG. Motor nerve sprouting. Ann Rev Neurosci 1981;4:17-42
48. Brown WF, Feasby TE. Conduction block and denervation in Guillain-Barré polyneuropathy. Brain 1984;107(Pt 1):219-239
49. Koirala S, Reddy LV, Ko CP. Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J Neurocytol 2003;32:987-1002 (Pubitemid 39011274)
50. Colomar A, Robitaille R. Glial modulation of synaptic transmission at the neuromuscular junction. Glia 2004;47:284-289
51. Rousse I, Robitaille R. Calcium signaling in Schwann cells at synaptic and extra-synaptic sites: Active glial modulation of neuronal activity. Glia 2006;54:691-699
52. Son YJ, Thompson WJ. Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells. Neuron 1995;14: 133-41
53. Son YJ, Thompson WJ. Schwann cell processes guide regeneration of peripheral axons. Neuron 1995;14:125-132
54. Crawley JN. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 1999;835:18-26
55. Tyc F, Vrbova G. The effect of partial denervation of developing rats fast muscles on their motor unit properties. J Physiol 1995;482:651-660
56. Slawinska U, Navarrete R, Kasicki S, et al. Motor activity patterns in rat soleus muscle after neonatal partial denervation. Neuromuscul Disord 1995;5:179-186
57. Wishart TM, Parson SH, Gillingwater TH. Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol 2006;65:733-739